| Name | Title | Contact Details |
|---|
Valley Aids Council is a Harlingen, TX-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
In every industry there is a company that thinks, and does things, differently. In employee group benefits, GroupHEALTH Benefits Solutions™ is that company. GroupHEALTH is transforming the way Canadians experience benefits by developing and delivering the most affordable, configurable, and usable benefit solutions to businesses across Canada. Leaders in employee benefits plans and group insurance, the GroupHEALTH Family of Companies has more than 500 employees in offices in Vancouver, Surrey, Calgary, Edmonton, Etobicoke, Woodbridge, and Barrie. With annual premiums exceeding $500 million and over $5 billion in pension assets under management, GroupHEALTH supplies market leading employee benefit services to more than 4,000 client organizations across Canada in both the public and private sectors, supporting more than 450,000 Canadians and their families.
Sernova Corp. is a clinical-stage biotechnology company that is developing its Cell Pouch System, a novel implantable and scalable medical device with immune protected therapeutic cells, for the treatment of chronic diseases such as insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. On implantation, the Cell Pouch forms a natural vascularized tissue environment in the body for the long-term survival and function of therapeutic cells that release essential factors absent or deficient in patients with certain chronic diseases. Sernova is also advancing a proprietary technology to shield therapeutic cells from immune system attacks with the goal to eliminate the need for chronic, systemic immunosuppression. In May 2022, the Company announced a global strategic partnership with Evotec, providing Sernova with a potentially unlimited supply of insulin-producing islet cells to treat patients with insulin-dependent diabetes (type 1 and type 2). Sernova continues to progress additional development programs utilizing its Cell Pouch System: a cell therapy for hypothyroid disease resulting from thyroid gland removal and an ex-vivo lentiviral Factor VIII gene therapy for hemophilia A.
Memorial Hospital is a proud part of University of Colorado Health, recognized as a national leader in quality and research. At the local level, Memorial provides a comprehensive list of inpatient and outpatient services at two hospitals and multiple outpatient locations. Memorial provides state-of-the-art, compassionate care in fields such as cardiology, neurology and oncology.
Massachusetts Hospital Association is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in Burlington, MA. To find more information about Massachusetts Hospital Association, please visit www.mhalink.org